Dr. Hirsch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University Of Washington Diabetes Institue
750 Republican, Building F, 3rd Floor
Seattle, WA 98109Phone+1 206-616-6732
Summary
- Dr. Irl Hirsch is an endocrinologist based in Seattle, WA, with subspecialties in diabetes and lipid metabolism. He completed his fellowship in endocrinology, diabetes, and metabolism at the Washington University/B-JH/SLCH Consortium after graduating from the University of Missouri-Columbia School of Medicine in 1984. Dr. Hirsch has served as a Professor of Medicine at the University of Washington School of Medicine since 1990. His expertise lies primarily in diabetes and hypoglycemia, and he has been involved in multiple clinical trials and published extensively in prominent journals. Notable publications include work in The Lancet, New England Journal of Medicine, JAMA, and Diabetes Care, focusing on diabetes research methodologies and treatment innovations. He has been recognized with awards such as America's Top Doctors by Castle Connolly.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1989
- University of Missouri-Columbia School of MedicineClass of 1984
Certifications & Licensure
- WA State Medical License 1990 - 2026
- FL State Medical License 1985 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Women's Health Castle Connolly, 2008
- Top MD Consumers Checkbook
Clinical Trials
- Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU Start of enrollment: 2006 Jun 01
- PERL Continuous Glucose Monitoring (CGM) Study Start of enrollment: 2017 Oct 01
Publications & Presentations
PubMed
- Response to Comments on Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care 2024;47:1257-1275.Guillermo E Umpierrez, Georgia M Davis, Nuha ElSayed, Gian Paolo Fadini, Rodolfo J Galindo
Diabetes Care. 2025-03-01 - 1 citationsA Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes.Irl B Hirsch, Roy W Beck, Martin C Marak, Yogish Kudva, Halis K Akturk
Diabetes Care. 2025-03-01 - The Role of a Continuous Glucose Monitoring-Derived Glycation Ratio in the Development of Microvascular Complications.Laura B Bovee, Theodore A Gooley, Jordan E Perlman, Irl B Hirsch
Diabetes Technology & Therapeutics. 2025-02-10
Journal Articles
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesAnuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA
- Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020Irl B Hirsch, Linda M Gaudiani, JAMA
- Connecting the Dots: Validation of Time in Range Metrics with Microvascular OutcomesKorey K Hood, Irl B Hirsch, Diabetes Care
- Join now to see all
Lectures
- Advances in Therapy2019 ACP Internal Medicine Meeting, Philadelphia - 4/10/2019
- 1st Annual Diabetes Symposium: New Advances and InnovationsJefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 9/28/2012
- Pregnancy Complicated by Diabetes and Severe Insulin Resistance (SIR): Review of 8 Cases on U-500 Regular Insulin (U500)Seattle, WA - 6/15/2014
Authored Content
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020
- Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020May 2020
Press Mentions
- What Did Your Breakfast Just Do to Your Blood Sugar? Continuous Glucose Monitoring Can ‘Empower’ the Diabetic and Non-Diabetic Alike, Experts SayJanuary 27th, 2025
- Preventing DKA in Patients with T1D on SGLT2 InhibitorsDecember 23rd, 2024
- Technosphere Insulin + Insulin Degludec Noninferior to Usual Care in T1DMDecember 17th, 2024
- Join now to see all
Committees
- member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2031
- member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
- member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
- member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
- member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
- member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: